Loading company…
Zylox develops medical devices for peripheral vascular and neurovascular intervention.
Founded in 2012 and based in Hangzhou, China, Zylox develops cardiovascular medical devices and has offices in Zhuhai, Beijing, and Shanghai. Its products include peripheral vascular stents, balloon dilation catheters, and devices for neurovascular intervention. The company reported 35 utility model patents and 9 invention patents; 34 of its 57 products under development had NMPA approval. Zylox raised USD 145 million in pre-IPO funding in June 2021 and listed on the Hong Kong Stock Exchange in July 2021. Revenue in 2022 was CNY 334.09 million.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in